Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

Tandem Meetings 2023 | Increasing access to survivorship care for CAR-T recipients

Nausheen Ahmed • 20 Feb 2023
Tandem Meetings 2023
General CAR-T

Nausheen Ahmed, MD, University of Kansas Medical Center, Westwood, KS, outlines strategies to grow survivorship programs for patients treated with CAR-T therapy. This interview took place at the 2023 Transplantation & Cellular Therapy Meetings of ASTCT™ and CIBMTR® held in Orlando, FL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

BMS: Advisory Board; KUMC – Kite Pharma: Research Funding

More from Nausheen Ahmed

1:18
Addressing disparities in access to CAR-T therapy for hematological malignancies
Nausheen Ahmed • 9 Jun 2023
0:47
Outcomes of outpatient tisa-cel recipients with B-NHL
Nausheen Ahmed • 9 Jun 2023
1:06
Exploring the role of CAR-T therapy in MCL & impact of prior treatment with BTKi or bendamustine
Nausheen Ahmed • 9 Jun 2023
0:47
Real-world outcomes of brexu-cel in patients with R/R MCL
Nausheen Ahmed • 9 Jun 2023

Related Videos

4:33
The EBMT Patient Advocacy Committee: Patient, Family and Donor Day at EBMT 2024
Natacha Bolaños • 16 Apr 2024
2:55
Distinguishing late-onset neutropenia from classical primary neutropenia
Carlo Dufour • 15 Apr 2024
2:39
The MAGIC algorithm probability to predict outcomes of GvHD in the GI tract
James Ferrara • 16 Apr 2024
2:25
The EBMT Trainee Committee: in-person trainee day at EBMT 2024 and upcoming initiatives
Claire Horgan • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals